What is the current Price Target for the Black Diamond Therapeutics Inc stock?

The average Black Diamond Therapeutics Inc target price is $10.20. This is 439.68% higher than the current stock price. The highest price target is 677.78%, the lowest is 327.51%. 9 Analysts have issued a price target Black Diamond Therapeutics Inc 2027 .

How high will the Black Diamond Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Black Diamond Therapeutics Inc stock will rise. The performance of stocks, including the Black Diamond Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Black Diamond Therapeutics Inc stock today?

The performance of Black Diamond Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Black Diamond Therapeutics Inc stock fall?

The decline in Black Diamond Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Black Diamond Therapeutics Inc Forecast, price target & analysts

$1.89

0.53%

Nasdaq, Sep 24, 04:00 pm EDT.

ISIN

US09203E1055

Symbol

BDTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Black Diamond Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Black Diamond Therapeutics Inc Classifications & Recommendation

Buy

86%

Hold

14%

Black Diamond Therapeutics Inc Price Target

Target Price	$10.20
Price	$1.89
Potential	439.68% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Black Diamond Therapeutics Inc 2027 . The average Black Diamond Therapeutics Inc target price is $10.20. This is 439.68% register free of charge higher than the current stock price. The highest price target is $14.70 677.78% register free of charge , the lowest is $8.08 327.51% register free of charge .
	A rating was issued by 14 analysts: 12 Analysts recommend Black Diamond Therapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Black Diamond Therapeutics Inc stock has an average upside potential 2027 of 439.68% register free of charge . Most analysts recommend the Black Diamond Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	0.39	-0.72
	130.71%	284.62%
P/E		negative

10 Analysts have issued a Black Diamond Therapeutics Inc forecast for earnings per share. The average Black Diamond Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$0.39	130.71%
2026	$-0.72 284.62% unlock
2027	$-0.97 34.72% unlock
2028	$-0.94 3.09% unlock
2029	$-1.15 22.34% unlock
2030	$-0.44 61.74% unlock
2031	$0.50 213.64% unlock
2032	$1.38 176.00% unlock
2033	$1.98 43.48% unlock

Current	-2.55	118.69%
2026	-2.64 3.36% unlock
2027	-1.94 26.52% unlock
2028	-2.00 3.09% unlock
2029	-1.65 17.50% unlock
2030	-4.33 162.42% unlock
2031	3.74 186.37% unlock
2032	1.37 63.37% unlock
2033	0.96 29.93% unlock

Black Diamond Therapeutics Inc...

Current Black Diamond Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BTIG	Locked ➜ Locked	Locked	Apr 29 2026
Wedbush	Locked ➜ Locked	Locked	Mar 17 2026
Piper Sandler	Locked ➜ Locked	Locked	Jan 16 2026
Guggenheim	Locked ➜ Locked	Locked	Dec 04 2025
Stifel	Locked ➜ Locked	Locked	Oct 16 2025
Guggenheim	Locked ➜ Locked	Locked	Sep 04 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 11 2025

Analyst Rating	Date
Locked BTIG: Locked ➜ Locked	Apr 29 2026
Locked Wedbush: Locked ➜ Locked	Mar 17 2026
Locked Piper Sandler: Locked ➜ Locked	Jan 16 2026
Locked Guggenheim: Locked ➜ Locked	Dec 04 2025
Locked Stifel: Locked ➜ Locked	Oct 16 2025
Locked Guggenheim: Locked ➜ Locked	Sep 04 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 11 2025

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 70.15%

Tencent Holdings Ltd. 56.53%

Uber Technologies 48.83%

Siemens Energy 47.15%

BYD 47.08%

Adidas 46.64%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now